CDH2 and esophageal cancer: In another recent study conducted on esophageal cancer cells, they observed that the derivative formed as a result of the hybridization of the heterocyclic chalcone skeleton and the dithiocarbamate compound slowed down growth depending on the dose and suppressed invasion and migration as a result of the decrease in N-cadherin and Slug biomarkers [70].